🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

S. Rasmussen

ORCID: 0000-0003-2309-4305
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Liraglutide reduces cardiovascular events and mortality in type 2 diabetes mellitus independently of baseline low-density lipoprotein cholesterol levels and statin use results from the LEADER trial”.

Liraglutide reduces cardiovascular events and mortality in type 2 diabetes mellitus independently of baseline low-density lipoprotein cholesterol levels and statin use results from the LEADER trial

UNC Libraries(2020)10.17615/ct1e-g414
N/A
0.104DataRank · unranked
1 citations

H. Bosch-Traberg, S. Rasmussen, S.C. Bain, S. Verma, J. Buse +7 more

Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure

Hypertension(2020)10.1161/hypertensionaha.120.14929
N/A
0DataRank · unranked
47 citations

Wen‐Yi Yang, Lutgarde Thijs, Yan Li, Kei Asayama, Tine W. Hansen +62 more

Effects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in patients with type 2 diabetes at high risk for cardiovascular events in the LEADER randomized trial. Diabetes Care 2019;42:1912-1920

UNC Libraries(2020)10.17615/hmrw-yb89
N/A
0DataRank · unranked
0 citations

H.A. Saevereid, E. Kreiner, S. Rasmussen, J.B. Buse, M.A. Nauck

Effects of liraglutide on cardiovascular outcomes in type 2 diabetes patients with and without baseline metformin use: Post hoc analyses of the LEADER trial

UNC Libraries(2020)10.17615/jxws-kt94
N/A
0DataRank · unranked
0 citations

S. Rasmussen, J.B. Buse, D.K. McGuire, S. Verma, A.-S. Alexopoulos +3 more